Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Articles

Majority of women’s healthcare providers reported in a survey feeling either somewhat or very comfortable with recommending or continuing acute treatments for pregnant patients with migraine. 	

Clinical Provider Survey Reveals Varied Levels of Comfort for Migraine Treatment During Pregnancy

Recruitment has begun for REGENXBIO's AFFINITY BEYOND clinical trial assessing the prevalence of AAV8 antibodies in male patients with Duchenne muscular dystrophy. 

REGENXBIO's Clinical Trial for Duchenne Therapy RGX-202 Begins Patient Recruitment 

Videos

The pediatric neurologist at Nationwide Children's Hospital talked about current gaps and potential treatment approvals in epilepsy care for 2023. [WATCH TIME: 4 minutes]  

Effective Comparative Research and Potential Treatment Approvals in Epilepsy Care: Anup Patel, MD

An exergaming program that spanned 8 weeks showed positive effects for patients with multiple sclerosis both with and without restless legs syndrome. 

Restless Legs Syndrome Severity in MS Decreased Through Exergaming

The chief training and education officer at the Parkinson’s Foundation provided perspective on the vast types of medical professionals who can learn from the organization’s new education series. [WATCH TIME: 4 minutes]

Educating and Easing Interdisciplinary Care Teams to Treat Parkinson Disease: Eli Pollard

, has been with the team since October 2019. Follow him on Twitter 

Donald Whiting, MD, chair of Allegheny Health Network’s Neurosciences Institute, provided insight on ADvance II, a multinational trial exploring the use of deep brain stimulation in patients with mild Alzheimer disease. 

Using Deep Brain Stimulation to Treat Alzheimer Disease Symptoms

Psychologist and professor in the department of rehabilitation medicine at the University of Washington

The psychologist and professor in the department of rehabilitation medicine at the University of Washington shared her perspective on the state of mental health care in multiple sclerosis. [WATCH TIME: 4 minutes]  

State of Mental Health Care for Patients With MS: Dawn Edhe, PhD

The executive direct of Cure CMD discussed the state of care for patients with congenital muscular dystrophies, the need for new treatments, and the patience with gene therapies.

NeuroVoices: Rachel Alvarez on Identifying Key Treatment Needs for Congenital Muscular Dystrophies

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

NMOSD

Narcolepsy

Parkinson Disease

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

The News Network video series features a variety of clinicians providing updates on the major data and paradigm-affecting updates from societal meetings and conferences focused on patients with neurologic diseases.

1rem

ACTRIMS 2020: Post-Conference Perspectives

ACTRIMS 2020 News Network: CLARITY Study on Relapsing Multiple Sclerosis

ACTRIMS 2020 News Network: Updated Data From the CLARITY Study

ACTRIMS 2020 News Network: EXPAND Study on Relapsing MS

ACTRIMS 2020 News Network: Effect of Disease Duration in the EXPAND Study 

ACTRIMS 2020 News Network: OPERA I/II Trials on Relapsing MS

ACTRIMS 2020 News Network: 6-Year Data With Ocrelizumab

ACTRIMS 2020 News Network: APLIOS Bioequivalence Study on Relapsing MS

ACTRIMS 2020 News Network: B-Cell Depletion in the Phase 2 APLIOS Study  

ACTRIMS 2020 News Network: Updated Recommendations for Standardized MRI Protocol in MS

ACTRIMS 2020 News Network: Standardized MRI Protocol for MS 

ACTRIMS 2020 News Network: An Overview of Other Exciting Data

Investigators caution health care providers to consider specific risks of severe COVID-19 infection before initiating this therapy.

Immunosuppressive DMTs Associated With Longer COVID-19 Hospitalization in Patients With Multiple Sclerosis